Literature DB >> 19470067

Psychological burden of anogenital warts.

I Dediol1, M Buljan, M Vurnek-A Ivkoviä, V Bulat, M A Itum, A A Ubriloviä.   

Abstract

BACKGROUND: Human papillomavirus (HPV) is one of the most common sexually transmitted diseases in the world, and anogenital warts are one of its various clinical manifestations. It has been shown that anogenital warts influence psychological status.
OBJECTIVE: The aims of this research were to evaluate the quality of life and illness perceptions and their relationship in patients with anogenital warts. Factors perceived as the main cause of their illness were also evaluated.
METHODS: Sixty male outpatients completed questionnaires: Brief Illness Perceptions Questionnaire and Quality of life in patients with anogenital warts.
RESULTS: Aspects of the quality of life most affected by anogenital warts were fear of contagiousness, concern about illness and everyday activities. The results showed that there is a weak influence of the disease on quality of life with changed perception of the illness. Patients with anogenital warts showed inadequate knowledge about their illness.
CONCLUSION: Psychological aspect of anogenital warts should not be neglected. Patient's education about HPV infection and their consequences should be emphasized.

Entities:  

Mesh:

Year:  2009        PMID: 19470067     DOI: 10.1111/j.1468-3083.2009.03242.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  9 in total

1.  Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know.

Authors:  Shrujal S Baxi; Andrew G Shuman; Geoffrey W Corner; Elyse Shuk; Eric J Sherman; Elena B Elkin; Jennifer L Hay; David G Pfister
Journal:  Head Neck       Date:  2012-11-20       Impact factor: 3.147

2.  [Conservative treatment of anogenital HPV infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

3.  Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach.

Authors:  Najmunnisa Nasreen; Nazli Khodayari; Kamal A Mohammed
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

4.  Cognitive and emotional responses to human papillomavirus test results in men.

Authors:  Ellen M Daley; Eric R Buhi; Stephanie L Marhefka; Elizabeth A Baker; Stephanie Kolar; Judith Ebbert-Syfrett; Cheryl A Vamos; Martha Abrahamsen; Anna R Giuliano
Journal:  Am J Health Behav       Date:  2012-11

Review 5.  Economic and humanistic burden of external genital warts.

Authors:  Adam J N Raymakers; Mohsen Sadatsafavi; Fawziah Marra; Carlo A Marra
Journal:  Pharmacoeconomics       Date:  2012-01       Impact factor: 4.981

6.  Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts.

Authors:  Scott Guenthner; Wendy McFalda; Melita Tate; Kimberly Eads; Jayson Rieger; David K Glover; Cynthia Willson; Pamela Rumney; Ted Rosen; Jennifer Andres; Melissa Olivadoti
Journal:  Am J Clin Dermatol       Date:  2021-09-13       Impact factor: 7.403

7.  HPV and genital warts among Peruvian men who have sex with men and transgender people: knowledge, attitudes and treatment experiences.

Authors:  César R Nureña; Brandon Brown; Jerome T Galea; Hugo Sánchez; Magaly M Blas
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

8.  HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients.

Authors:  Marion Piñeros; Gustavo Hernández-Suárez; Liliana Orjuela; Juan Carlos Vargas; Gonzalo Pérez
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295

9.  Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK.

Authors:  Géraldine Dominiak-Felden; Catherine Cohet; Samantha Atrux-Tallau; Hélène Gilet; Amanda Tristram; Alison Fiander
Journal:  BMC Public Health       Date:  2013-11-12       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.